What's happening
Ozempic and other GLP-1 agonists (Wegovy, Mounjaro, Zepbound) are linked to severe gastroparesis, intestinal obstruction, and gallbladder injuries.
Why it matters
MDL 3094 consolidated February 2024 in E.D. Pennsylvania before Judge Pratter. Bellwether selection underway. First trials projected late 2026. Over 1,800 cases pending federally; thousands more in state court.
Recommended action
Open intake now. The bellwether window is the lowest-CPL period of any GLP-1 docket. Geographic priority: PA, NY, NJ, FL, TX, CA. Document medication history, hospitalization records, and pre-existing GI conditions for case strength scoring.